A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course

Background: The diagnostic use of biomarkers in body fluids of multiple sclerosis (MS) patients allows the monitoring of different pathophysiological aspects of the disease. We previously reported elevated cerebrospinal fluid (CSF) and serum levels of glial fibrillary acidic protein (GFAP) but not n...

Full description

Bibliographic Details
Main Authors: André Huss, Markus Otto, Makbule Senel, Albert C. Ludolph, Ahmed Abdelhak, Hayrettin Tumani
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
CSF
serum
glial markers
neurofilament light chain
progressive MS
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00608/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.00608/full

Similar Items